Table 4. Prevalence of diabetes markers in subjects with elevated thyroid autoantibodies.

	Anti-TPO+	Anti-TPO−	P value	Anti-Tg+	Anti-Tg−	P value
HOMA-IR positive	45.5% (1869/4104)	37.5% (11 015/29 387)	<0.0001	41.1% (1747/4255)	37% (8285/22 364)	<0.0001
High HbA1C	16.3% (990/6076)	15.4% (6502/42 088)	0.0930	14% (872/6210)	14.7% (4701/32 057)	0.2100
Low ADIP	2.2% (94/4184)	3.1% (918/29 592)	0.0028	1.7% (74/4391)	3% (671/22 699)	<0.0001
High glucose	22.1% (1001/4525)	22% (7097/32 218)	0.9022	19.8% (908/4595)	21.5% (5186/24 139)	0.0093
Low glucose	1.7% (75/4525)	1.8% (567/32 218)	0.6659	1.8% (84/4595)	1.9% (463/24 139)	0.7262
Low glymark	10.3% (314/3058)	10.1% (2250/22 345)	0.7564	8.6% (259/2998)	10.1% (1509/14 881)	0.0132
GSP	10.7% (438/4104)	10.7% (3159/29 601)	1.0000	11.3% (476/4215)	11.4% (2540/22 266)	0.8507
High insulin	14.1% (266/1888)	11.5% (4490/39 169)	0.0006	11.2% (588/5238)	11.1% (2990/26 991)	0.7735
Low insulin	2.9% (144/5005)	2.8% (986/34 815)	0.8936	2.8% (149/5238)	2.8% (764/26 991)	0.9916

ADIPAdiponectinGSPGlycated serum proteinHbA1cGlycated hemoglobinHOMA-IRhomeostatic model assessment-insulin resistanceTgThyroglobulinTPOThyroid peroxidase